Clinical Trial Update: Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of ALVR106 in patients with respiratory tract viral infections after hematopoietic cell or solid organ transplantation was terminated, and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Metapneumovirus Infection
• Influenza Infection
• Parainfluenza Virus Infection
• Respiratory Syncytial Virus Infection
• Respiratory Tract Infections

Drugs mentioned

• ALVR106

Snippet

Sponsor: AlloVir | Conditions: Respiratory Tract Viral Infections, Human Metapneumovirus (hMPV) Infection | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-06-06